Life Sciences leader Daphne Lainson recognized in the IAM Strategy 300 Global Leaders 2024 edition

Smart & Biggar is proud to announce that Principal and Life Sciences practice group leader, Daphne Lainson, has been honoured in the 2024 edition of IAM Strategy 300 Global Leaders.

The IAM Strategy 300 Global Leaders guide showcases the top experts in the IP world and is the only resource that recognizes IP leaders from in-house, private practice, and consulting. Inclusion in the guide is the “mark of a professional whose approach to intellectual property is regarded by peers as truly strategic in nature”.

Daphne is a trusted IP counsellor and advisor to global innovators who works with clients to achieve success in the complex life sciences patent-regulatory landscape, providing strategic advice across the patent life cycle of innovative drugs and medicines.

IAM editors commented “Daphne Lainson is, without a doubt, one of the top life sciences patent attorneys in Canada. She is sought out by those in the pharmaceutical sector to help with their decision-making regarding their most valuable assets thanks to her vast knowledge of patent and regulatory law”.

Read more about Daphne in her exclusive Q&A interview with IAM.

Congratulations to Daphne on this recognition, and for leading the way in the patent industry while helping innovative life science clients to develop and implement comprehensive IP strategies, that strengthen the value of IP portfolios.

Learn more about the guide and view the full list of the 2024 IAM Strategy 300 Global Leaders online.

About Smart & Biggar

Smart & Biggar is widely recognized as Canada’s leading intellectual property firm, with offices in Montréal, Ottawa, Toronto, Vancouver and Calgary. We are leaders in intellectual property and have been serving clients for over a century. Smart & Biggar operates as part of the IPH Limited group, under its own brand and independent from other IPH member firms.